Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area stem cell stem gsk 3'

Search results for: 'research area stem cell stem gsk 3'

Items 61-70 of 151

Page
per page
  1. Valrocemide
    B6100 Valrocemide
    Summary: anticonvulsant agent
      insoluble in H2O; ≥20 mg/mL
  2. ML-264
    C3474 ML-264
    Summary: Krüppel-like factor 5 (KLF5) inhibitor
      ≥48.6 mg/mL
  3. PTC209 HBr
    B4971 PTC209 HBr
    Summary: BMI-1 inhibitor
      ≥22.9 mg/mL
  4. Sodium Tauroursodeoxycholate (TUDC)
    B6019 Sodium Tauroursodeoxycholate (TUDC)
    Target: BCPCF efflux
    Summary: water soluble bile salt
      ≥26.1 mg/mL
  5. GMX1778 (CHS828)
    B6031 GMX1778 (CHS828)
    Summary: NAMPT inhibitor
      insoluble in H2O; insoluble in EtOH; ≥18.3 mg/mL
  6. Ataciguat
    C4216 Ataciguat
    Summary: activator of the oxidized (heme-free) form of soluble guanylate cyclase (sGC)
      ≤1 mg/mL
  7. Cytochalasin H
    C4309 Cytochalasin H
    Summary: inhibitor of actin incorporation into filaments
      Soluble in DMSO
  8. EUK 118
    C4669 EUK 118
    Summary: inhibitor of superoxide-mediated reduction of an electron acceptor
      ≤1 mg/mL
  9. 12(S)-hydroxy-16-Heptadecynoic Acid
    C5001 12(S)-hydroxy-16-Heptadecynoic Acid
    Summary: mechanism-based inhibitor of cytochrome P450 ω-hydroxylase
      ≤50 mg/mL
  10. S-methyl-L-Thiocitrulline (hydrochloride)
    C5504 S-methyl-L-Thiocitrulline (hydrochloride)
    Summary: potent NOS inhibitor
      ≤75 mg/mL

Items 61-70 of 151

Page
per page
Shop By
Now Shopping by
  1. Category Others Remove This Item
Clear All
Shopping Options
Category
  1. Actin 4item
  2. Adenylate cyclase 1 item
  3. AhR 7item
  4. Antioxidants 3item
  5. BCRP 1 item
  6. CaM kinase II 3item
  7. Cell Adhesion Molecules 1 item
  8. Cell Penetrating Peptide 1 item
  9. Cytokine 2item
  10. Enzyme Substrates / Activators 1 item
  11. ES-FLI1/RHA 1 item
  12. FLAP 1 item
  13. Fluorescent Probes 2item
  14. FXR 1 item
  15. GLI 1 item
  16. Glycoprotein 2item
  17. Glycosylases 1 item
  18. Guanylate Cyclase 1 item
  19. Hexokinase 1 item
  20. Hydroxylases 3item
  21. iNOS 1 item
  22. Inositol Phosphatases 1 item
  23. LXR 2item
  24. Matrix Metalloprotease 1 item
  25. MDR multidrug resistance 1 item
  26. Menin-MLL 1 item
  27. Miscellaneous Compounds 1 item
  28. Myosin 3item
  29. NAE 1 item
  30. NADPH Oxidase 1 item
  31. Nampt 1 item
  32. Natriuretic Peptide Receptors 2item
  33. nNOS 2item
  34. Nuclear Receptors 2item
  35. Oxygenases/Oxidases 1 item
  36. PGC-1α 1 item
  37. RARs 4item
  38. Reagents 7item
  39. Reductases 3item
  40. SGK 2item
  41. SPHK 1 item
  42. Synthases/Synthetases 2item
  43. Thrombopoietin Receptor 1 item
  44. Transcription Factors 3item
  45. β(1,3)-D-Glucan Synthase 1 item
  46. Others 51item
  47. BMI-1 1 item
  48. SOD 1 item
  49. Homodimerizers 1 item
  50. Protein synthesis 1 item
Specificity
  1. Selective 24item
Reversibility
  1. Irreversible 2item
Target
  1. Glycoproteins 1 item
  2. P-glycoprotein (P-gp) 1 item
  3. SGK 2item
  4. Liver X receptors (LXRs) 1 item
  5. Microtubules/Tubulins 1 item
  6. BMI-1 1 item
  7. Ca2 /calmodulin-dependent protein kinases (CaMKs) 3item
  8. BCPCF efflux 1 item
  9. P2X Receptors 1 item
  10. TAK1 1 item
  11. RAR/RXR 1 item
  12. DYRK 1 item
  13. Aldosterone receptor 1 item
  14. NAE 1 item
  15. Ubiquitin-activating Enzyme E1 1 item
  16. SUMOylation 1 item
  17. ATGL 1 item
  18. Menin-MLL 1 item
  19. quinone oxidoreductase 1 item
  20. Rev-Erb Receptors 1 item
  21. Aryl hydrocarbon receptors (AHRs) 1 item
  22. RHA 1 item
  23. FKBP 1 item
  24. FXR 1 item
Reported Experiments
  1. Animal Experiments 23item
  2. Cell Experiments 23item
Related Disease
  1. Breast Cancer 1 item
  2. Cancer 8item
  3. Colon Cancer 2item
  4. Colorectal Cancer 2item
  5. Dyslipidemia 1 item
  6. HIV 1 item
  7. Inflammatory Diseases 2item
  8. Leukemia 2item
  9. Lung Cancer 1 item
  10. Lymphoma 1 item
  11. Melanoma 1 item
  12. Non-small Cell Lung Cancer 1 item
  13. Ovarian Cancer 1 item
  14. Prostate Cancer 1 item